LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. - Wikidata - wikimedia - TriplyDB

LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.

LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.

http://www.wikidata.org/entity/Q35793883

about

Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis Decoding the usefulness of non-coding RNAs as breast cancer markers Long non-coding RNAs in anti-cancer drug resistance Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer.Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer LncRNAs: From Basic Research to Medical Application NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression.Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer.Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer.Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer.Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer.Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.lncRNA expression character associated with ischemic reperfusion injury.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Long noncoding RNAs in regulation of human breast cancer.Expression analysis of long non-coding ATB and its putative target in breast cancer.Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance.Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.Breast cancer stem cells programs: enter the (non)-code.IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma.miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.Long noncoding RNAs in gastric cancer carcinogenesis and metastasis.Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.Role of long non-coding RNA in tumor drug resistance.LncRNA-SLC6A9-5:2: A potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction.What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

P2860

Q26765464-873F83B1-DBEC-4B36-9D70-458ECB339B10 Q28066271-BDE8CD47-5BE3-45F1-BDDA-596B836E4FC7 Q28069370-DE73E495-1084-4B0A-B204-BD480DA91223 Q28072366-0F3E7016-FF88-4085-B0E3-0DCD0002DD7E Q33623211-02A1B795-E4AB-452C-A08E-AA1C2C7B61A9 Q33787422-C47A16E6-135A-42D7-B8BD-86D892D48876 Q33850652-BD662F8B-791F-4006-907F-D6422D610075 Q36095338-BA2A9CF6-AA1E-429D-BA05-B9DA42A15A4F Q36331304-5D093368-8AF7-4A4D-9E77-D3C8EA4539E3 Q36413858-C22D67AB-13C3-497E-B0E2-1C80E4594AEA Q36511756-C87F5ADF-C332-49C7-B49C-A28E4689D34F Q36544839-3C6B6170-4F5E-4AF1-8BD5-F78FEB0B5CB2 Q36633508-01FBEB3F-FA91-4C7D-B7A3-6F9A66EC1673 Q36772092-F8CFDCA0-9257-47C2-AD65-4A1782C5824A Q36976091-7ACA1A52-C27C-4EB9-9E36-78254E05356A Q37022374-C24FC833-62DA-4C53-A526-5C3654BD4F1A Q37225623-416D6F77-1723-4601-A563-A914D0623643 Q37317395-69423F84-D3F2-4AA5-BB08-A79302FBC769 Q37327474-4EF8CD4F-51F7-4FA9-956A-70E3250B4631 Q37457902-46FC4675-E305-4CBD-816C-4842AF7C1CBD Q37696368-A5326FEB-FB0E-4C7D-A094-0E3E23369E4D Q37706387-8F5B7FFF-9940-4A2C-891F-CB65397CA504 Q37709040-59BD1BC2-0000-4F7A-8DCF-5E6110E2D582 Q38430921-9D01E862-F8A4-42DE-B4DF-0B6A43CFD3F7 Q38546133-938F555B-AE5B-4C92-9C58-DF92B4835534 Q38638146-EB28F21F-A090-4771-BCA7-793F8A7739CC Q38672826-DB835917-7949-4DA0-A086-CAC9B1DDD9F4 Q38703402-EE14DEBA-5EF9-4E32-AC29-ACEDCA61434D Q38704737-46588A2B-BC5B-4370-BDA3-29F12A3C1CB9 Q38729414-53B6774C-3F56-4B01-A263-BE7A7016E9F9 Q38732993-2C02183C-63CF-4C01-A7A6-BA4045303E0B Q38739217-7A305634-B5FF-4D11-8172-2609EAA7005F Q38765793-7278878D-4858-4E92-9AD8-19EB3B16B5F9 Q38804266-515142D3-E382-40DE-AD63-A84CCAA8A101 Q38812266-4DED94EC-C52F-41DC-93BF-D260F02BD473 Q38819547-16010789-9840-4998-BC01-E92E2A4069E8 Q38826625-7019BEC1-E75B-4B21-AE7D-5CBE6BB5D3AB Q38886641-71F6D54D-92A8-453B-AFBA-FBE511848E69 Q39021756-D83FA2BD-ABB3-4054-A697-EFAA5D2F791E Q39168132-3A3AC04E-03BD-44B4-820F-EE0D91E7D71E

P2860

LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.

http://www.wikidata.org/entity/Q35793883

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@ast

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@en

type

label

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@ast

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@en

prefLabel

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@ast

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@en

P1433

Q35793883-33E9AB7D-A9E6-4A71-8AE1-7EF9FDC63C68

P1476

Q35793883-95AB1CD5-94ED-4226-BC25-B8718E4A9E95

P2093

Q35793883-18CD98A2-6BC1-4CD1-B36A-8EE7C529B134

Q35793883-2CA5AEE0-0B9E-43DC-8051-74F3BEB8F6A5

Q35793883-952F23DF-4650-452F-A161-0AEF7F80AC3B

Q35793883-96FA5C2F-90A7-48C3-9BBE-AF87B09C6B80

Q35793883-B01207FB-892F-4F87-A97D-F4E8B17B1A24

Q35793883-C85C81A9-41F5-4A86-8471-EED97647CA87

P2860

Q35793883-00F4195D-56A8-46AD-8C23-DAFF07BA5EB1

Q35793883-14FE82D8-5205-4CB8-9445-D3B864D4CDF4

Q35793883-1F15CAE6-6C15-424F-8206-022E57461D7A

Q35793883-28A1AF71-B782-4D58-A95E-5C90F15E16C1

Q35793883-38997F74-26EB-42B7-8B76-A66284B2C5AF

Q35793883-3E668B88-DCA0-48F6-9307-F918A3EEC7FE

Q35793883-50798D45-4584-4D11-B8D8-C022B568195F

Q35793883-50CA766D-1BDB-4DC9-A978-856447595AE5

Q35793883-50CF27A5-AF9B-4BB8-9752-6CB77EDB1A1E

Q35793883-522CC24E-2470-41E4-8E13-A48C3935CCAB

P304

Q35793883-A90DEF58-36F8-4B20-880F-8F864D1E42CD

P31

Q35793883-AAE857EA-F37A-4D22-A229-FCC9E157DC4C

P356

Q35793883-49CF79E6-6028-4B0F-9FB1-038B1DF68D35

P407

Q35793883-54889A3D-477B-4318-A171-500AB349357E

P433

Q35793883-7B92C13A-C6A9-4A6B-B679-52317CAFCB4A

P478

Q35793883-7466F3A5-637A-4C66-8E84-017038A25401

P577

Q35793883-B2A1265C-926D-42C0-81CF-75DE9B44CF19

P5875

Q35793883-0275416F-462E-44AB-81E7-F5CFA8FD81A6

P698

Q35793883-E61105CF-3082-4A29-BC6A-7D23BBDD4784

P932

Q35793883-A68F16AC-6400-4051-AF7A-231342F62C59

P356

ONCOTARGET.3457

P1433

P1476

LncRNA-ATB promotes trastuzuma ...... asis cascade in breast cancer.

@en

P2093

Bo Yu

http://www.w3.org/2001/XMLSchema#string

Li-Juan Wang

http://www.w3.org/2001/XMLSchema#string

Sheng-Jia Shi

http://www.w3.org/2001/XMLSchema#string

Xiao-Zhong Bai

http://www.w3.org/2001/XMLSchema#string

Yong Jin

http://www.w3.org/2001/XMLSchema#string

Yun-Hui Li

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Cancer statistics, 2014

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

TGFbeta in Cancer

Evolution and functions of long noncoding RNAs

A four-long non-coding RNA signature in predicting breast cancer survival.

Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.

P304

11652-11663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3457

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274964629

http://www.w3.org/2001/XMLSchema#string

P698

25871474

http://www.w3.org/2001/XMLSchema#string

P932

4484483

http://www.w3.org/2001/XMLSchema#string